Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization

被引:7
作者
Dettke, M
Jurko, S
Rüger, BM
Leitner, G
Greinix, HT
Kalhs, P
Fischer, MB
Höcker, P
机构
[1] Univ Hosp Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria
[2] Univ Hosp Vienna, Dept Internal Med 1, Bone Marrow Transplantat Unit, Vienna, Austria
来源
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH | 2001年 / 10卷 / 02期
关键词
D O I
10.1089/15258160151135105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of granulocyte colony-stimulating factor (G-CSF) induced mobilization of peripheral blood progenitor cells (PBPC) on the endogenous serum levels of cytokines stem cell factor (SCF) and flt3-ligand (flt3-L) was studied in 18 healthy subjects undergoing allogeneic PBPC donation. Donors received a standardized mobilization regime consisting of a 4-day course of G-CSF, with leukapheresis on day 5. Endogenous serum flt3-L and SCF were determined prior to G-CSF administration, on the day of leukapheresis, and followed up until day +100 after cessation of G-CSF administration. The administration of G-CSF resulted in a transient elevation of endogenous flt3-L serum levels. At the day of leukapheresis serum flt3-L showed a median increase of 75% compared to serum flt3-L levels obtained before G-CSF treatment. The increase in serum flt3-L levels showed no correlation with the total number of progenitor cells mobilized. Cessation of G-CSF treatment led to normalization of serum flt3-L within 7 days post G-CSF administration. In contrast, serum CSF levels remained unchanged in response to G-CSF administration. Our results demonstrate a transient surge in serum flt3-L in relation to G-CSF-induced PBPC mobilization, although the assessment of endogenous flt3-L give no information regarding the ability for G-CSF-induced PBPC recruitment in healthy individuals.
引用
收藏
页码:317 / 320
页数:4
相关论文
共 13 条
[1]  
Blumenthal RD, 2000, CANCER, V88, P333, DOI 10.1002/(SICI)1097-0142(20000115)88:2<333::AID-CNCR13>3.0.CO
[2]  
2-D
[3]   High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34+ PBSC in patients undergoing high-dose chemotherapy and stem cell rescue [J].
Gazitt, Y ;
Liu, Q .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (02) :285-293
[4]   Blood and marrow transplantation activity in Europe 1997 [J].
Gratwohl, A ;
Passweg, J ;
Baldomero, H ;
Hermans, J .
BONE MARROW TRANSPLANTATION, 1999, 24 (03) :231-245
[5]   LIGAND FOR FLT3 FLK2 RECEPTOR TYROSINE KINASE REGULATES GROWTH OF HEMATOPOIETIC STEM-CELLS AND IS ENCODED BY VARIANT RNAS [J].
HANNUM, C ;
CULPEPPER, J ;
CAMPBELL, D ;
MCCLANAHAN, T ;
ZURAWSKI, S ;
BAZAN, JF ;
KASTELEIN, R ;
HUDAK, S ;
WAGNER, J ;
MATTSON, J ;
LUH, J ;
DUDA, G ;
MARTINA, N ;
PETERSON, D ;
MENON, S ;
SHANAFELT, A ;
MUENCH, M ;
KELNER, G ;
NAMIKAWA, R ;
RENNICK, D ;
RONCAROLO, MG ;
ZLOTNIK, A ;
ROSNET, O ;
DUBREUIL, P ;
BIRNBAUM, D ;
LEE, F .
NATURE, 1994, 368 (6472) :643-648
[6]   c-kit ligand and flt3 ligand:: Stem/progenitor cell factors with overlapping yet distinct activities [J].
Lyman, SD ;
Jacobsen, SEW .
BLOOD, 1998, 91 (04) :1101-1134
[7]  
LYMAN SD, 1995, BLOOD, V86, P4092
[8]   Chronic overexpression of membrane-bound flt3 ligand by T lymphocytes in severe aplastic anaemia [J].
Pfister, O ;
Chklovskaia, E ;
Jansen, W ;
Mészáros, K ;
Nissen, C ;
Rahner, C ;
Hurwitz, N ;
Bogatcheva, N ;
Lyman, SD ;
Wodnar-Filipowicz, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) :211-220
[9]   Synergy of growth factors during mobilization of peripheral blood precursor cells with recombinant human Flt3-ligand and granulocyte colony-stimulating factor in rabbits [J].
Pless, M ;
Wodnar-Filipowicz, A ;
John, L ;
Baldomero, H ;
Lyman, SD ;
Nissen, C ;
Gratwohl, A .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (01) :155-161
[10]   Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of α4β1 integrin expression and function [J].
Prosper, F ;
Stroncek, D ;
McCarthy, JB ;
Verfaillie, CM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2456-2467